Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Selvaag Bolig ASA: Invitation to presentation of third quarter 2019 results

Selvaag Bolig ASA will publish its third quarter 2019 results Wednesday 13 November at 07:00 am CET. The quarterly report and the presentation materials will be available on the company's website, www.selvaagboligasa.no/en and www.newsweb.no, as well as news wires. CEO Rolf Thorsen and CFO Sverre Molvik will present the company's results at 08:30 am CET at Høyres Hus, Stortingsgaten 20 in Oslo. A light breakfast will be served from 08:00. The presentation will be held in Norwegian and transferred via live webcast. The link to the webcast can be found on the company's website. It

Albin de Beauregard resigns as CFO of Kindred

Kindred Group’s CFO, Albin de Beauregard, has decided to step down from his role and leave Kindred Group during the first quarter of 2020. The process to find a new permanent CFO has started.Kindred Group’s Chief Financial Officer (CFO), Albin de Beauregard, has taken the decision to leave Kindred Group during the first quarter of 2020 following eight successful years within the Group, with four of those years as CFO. Albin will continue to oversee the closing of the 2019 financial year. Graham Stretch, former CFO at Kindred Group, will provide support during the transition period and

Polygon announces consent solicitation and subsequent notes via Nordea

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OR TO ANY PERSON LOCATED OR RESIDENT IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. Polygon AB (publ) announces a consent solicitation for its outstanding senior secured fixed rate notes due 2023 (ISIN SE0010830950) (the "Notes"), mandate announcement for an issue of Subsequent Notes and certain new pro forma financial information.Polygon AB (publ) reg. no. 556816-5855 (the "Company") announces that it is soliciting consent from the holders of the Notes (the "Noteholders") to obtain

OrganoWood enters distribution agreement with Carl Götz in Germany

OrganoClick’s subsidiary OrganoWood has entered into a sales and distribution agreement with the German wood distributor Carl Götz GmbH. The agreement gives Carl Götz a non-exclusive right to sell and distribute OrganoWood®-wood in Germany, Austria and Switzerland. [OrganoWood trall] Carl Götz is a leading German distributor of wood and wood based products. The company has a total of 15 distribution centers and warehouses throughout Germand and supplies leading building suppliers and DIY-stores in Germany, Austria and Switzerland. “Carl Götz is looking forward in starting sales and

SEMAFO: Attack on the Road Between Fada and Boungou in Est Region

Montreal, Quebec, November 6, 2019 /CNW/ – SEMAFO Inc. (TSX, OMX: SMF) (“SEMAFO”) regrets to report there was an attack on the road between Fada and the Boungou Mine site in the Est region of Burkina Faso. The incident happened approximately 40 kilometers from the Boungou Mine. The convoy, escorted by military personnel, comprised five buses transporting SEMAFO national employees, contractors and suppliers. Information currently has several fatalities and injuries. We will issue a more fulsome statement when complete details are known. Boungou mine site remains secured and our operations

Decisions taken at the Extraordinary General Meeting of myFC Holding AB (publ)

At today's Extraordinary General Meeting of myFC Holding AB (publ), decisions were taken in accordance with the Board of Directors’ proposal: to carry out a directed issue of shares to H119 Ltd, to elect two new Board members, and their remuneration.The Annual General Meeting took the decisions listed below. All decisions were in accordance with the proposals presented and are described in detail in the EGM documents available on the company's website www.myfc.se. · Decision to issue 46,900,000 shares. The subscription price is SEK 0.45 per share. · Decision to elect Markus Hermanek

PAYDAY 2™: SILK ROAD out November 7

With the first release since late 2018, the all new SILK ROAD update features a free core game update available for all owners of PAYDAY 2 introducing the suit customization system, as well as a new heist, outfit and mod pack available for purchase Starbreeze Studios and OVERKILL - a Starbreeze Studio have announced the release of the latest content for PAYDAY 2: the “Silk Road” campaign, featuring a suit customization system and six outfits added for free, as well as “Border Crossing Heist” DLC, “Tailor Pack 1” DLC, and “Cartel Optics Mod Pack” DLC, available at $6.99, $2.99

Appointment of Greg Smith as CEO of Endomines AB (publ)

Endomines AB, Stock Exchange Release 6 November 2019, at 15:00 CET Endomines is pleased to announce that it has today appointed Greg Smith as Chief Executive Officer of the company. Greg has, on a consultancy basis, been leading Endomines’ operations in the US and Finland since June 5[th ]2019, when Endomines communicated that it was evaluating the appointment of Greg as CEO of Endomines. Greg Smith will assume the position of CEO as soon as he has been granted a Swedish work permit (Sw. ICT-tillstånd), which is expected to be granted in February 2020, by the latest. Greg Smith has a

Neonode Reports Third Quarter Ended September 30, 2019 Financial Results

STOCKHOLM, SWEDEN – November 6, 2019 – Neonode Inc. (NASDAQ: NEON), the optical interactive sensing technology company, today reported financial results for the three and nine months ended September 30, 2019.”There is significant interest for Neonode’s sensor and license technology in the automotive and other key markets but in our business, we have to accept long lead times in acquiring new customer contracts. Having said that, we are not satisfied with the development over the last 12-18 months. Our newly recruited CEO, Dr. Urban Forssell, brings a deep understanding of the automotive

Oncopeptides to Highlight Data from Melflufen Clinical Program in Multiple Myeloma and AL Amyloidosis in Six Presentations at ASH Annual Meeting 2019

STOCKHOLM — November 6, 2019 — Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that data from the clinical program evaluating its lead candidate melflufen in multiple myeloma and Light Chain (AL) Amyloidosis have been selected for six poster presentations to be featured at the American Society of Hematology (ASH) 2019 Annual Meeting taking place December 7-10 in Orlando, Florida. Melflufen is a peptide-conjugated alkylator belonging to the novel class of Peptidase Enhanced Cytotoxics (PEnC).A wide range of clinical and preclinical data for melflufen in both multiple myeloma and AL

Notice from bondholders' meeting DOF Subsea AS

Reference is made to the summons to a bondholders' meeting in DOFSUB07 (ISIN NO 001 0670144) issued on 22 October 2019. The bondholders' meeting was held today, and the proposed resolution was approved by 100% of the votes in cast at the bondholders' meeting. The bond agreement for DOFSUB07 will therefore be changed as set out in the summons. The minutes from the bondholders' meeting is attached. For further information, please contact: CEO Mons Aase, tel. +47 91 66 10 12 CFO Hilde Drønen, tel. +47 91 66 10 09

Updates from Keliber Oy

Today, Keliber Oy (“Keliber”) announced the extraordinary general meeting’s appointment of Mr. Mika Seitovirta (M.Sc.Econ) as the new Chairman of the Board of Directors. In a separate notice Keliber also provided a project update, including the identification of certain factors that need to be further assessed and planned, which impacts the project timeline. Due to the changes in end product and production process, additional technical and environmental planning has been required. Keliber has also evaluated the length of the upcoming construction and updated the construction master

Mika Seitovirta has been appointed as a Chairman of the Board of Keliber Oy

Keliber Oy's Extraordinary General Meeting held on November 6, 2019 appointed Mr. Mika Seitovirta (M.Sc. Econ) as the new Chairman of the Board of Directors. Seitovirta has extensive international experience in managing global companies. He has previously served as CEO of Outokumpu Oyj, Glaston Corporation and Hartwall / Scottish & Newcastle, among others. Currently, Seitovirta works as an advisor and a Board professional in Finland and internationally. "I am proud and excited to be part of developing Keliber’s lithium project towards construction and production phase. The company's

Transfer of EAB Group’s own shares

EAB Group Plc, Stock Exchange Release, 6 November 2019, 3:30 p.m. (EET) Transfer of EAB Group’s own shares On 6 November 2019, EAB Group Plc transferred a total of 3,247 own shares held by the company to the key employees of the company without consideration. The transfer is related to the payment of deferred variable remuneration and is in accordance with the Company's remuneration scheme. The regulation requires that, to the extent that a reward scheme for so-called risk-takers may result in a variable remuneration of more than €50,000 per calendar year, at least 40% of the

Orkla ASA: Issuance of Commercial Paper

Orkla ASA has issued a commercial paper of NOK 300,000,000. Start date:                  11 November 2019Maturity:                     11 December 2019Coupon:                     1.73 %Organised by:             Handelsbanken Markets       Orkla ASAOslo, 6 November 2019 Ref.: Senior Vice President Group TreasuryGeir SolliTel.: +47 995 42 789 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Alligator Bioscience: ATOR-1017 Induces Long-Lasting Immunity – New Preclinical Data to be presented at SITC 34th Annual Meeting

Lund, Sweden, November 6, 2019 – Alligator Bioscience (Nasdaq Stockholm: ATORX), today announced that the company will present new preclinical data showing that their drug candidate ATOR-1017 can induce a long-lasting immunological memory which is of great importance in a potential future patient setting. The results will be presented at the ongoing Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting. The ATOR-1017 drug candidate is in development for the treatment of metastasized cancer. Furthermore, the results show that treatment with ATOR-1017 activates the immune system

Saab’s New Electronic Attack Jammer Pod in the Air

Saab carried out the first flight tests with its new advanced Electronic Attack Jammer Pod (EAJP) with successful results on 4 November 2019. The pod’s interfaces with the aircraft’s hardware and software as well as cockpit control and monitoring were tested during the flight.The purpose of Saab’s new EAJP pod is to protect aircraft against radars by sophisticated jamming functions, thereby blocking the opponent’s ability to attack them. The first flight marks an important step of the pod’s development programme. Saab is sharpening its electronic attack capabilities and the new advanced

STRAX: URBANISTA CONTINUES TO DELIVER

Urbanista, the lifestyle audio brand owned by STRAX, continues its path towards a record year in 2019.Following the success of the true wireless headphones Stockholm which remains one of the fundamental products in the Urbanista product portfolio, Urbanista has this fall launched two additional true wireless headphones – Paris and Athens – as well as two true wireless speakers – Sydney and Brisbane – all addressing the true wireless opportunity, the fast growing market segment of the global audio industry. During the year Urbanista has entered into several important collaborations, for

InCoax Networks AB (publ) announces the results of the rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE.The subscription period for the new share issue in InCoax Networks AB (publ) (“InCoax” or the “Company”) with preferential rights for existing shareholders (the “Rights Issue”) was completed on November 1, 2019. The outcome of the Rights Issue, which was covered by subscription and guarantee commitments corresponding to 80

TrustShield™, Ahlstrom-Munksjö’s single-use medical fabrics for ultimate protection in the operating room, clinical environment and laboratory

AHLSTROM-MUNKSJÖ, PRESS RELEASE, NOVEMBER 6, 2019 at 2:30 P.M. EET Ahlstrom-Munksjö announces the launch of TrustShield™, a versatile portfolio of medical fabrics that can be used to provide protection against surgical lasers, chemicals and potent chemotherapy drugs. TrustShield™ products were specially designed around growing market trends. The evolution of laser technology in a surgical environment has significantly advanced as their usage has become widespread for numerous specialties. Although there are many benefits to using lasers for surgical procedures, there are also risks.

Invitation to 3Q 2019 presentation

Otello Corporation ASA is presenting its 3Q 2019 results on Wednesday, November 13, 2019, at 08:00am CET. The presentation will take place at Felix Konferansesenter, Bryggetorget 3, Oslo, Norway. A live webcast will be available at: https://otellocorp.com/ir   Petter Lade, CFO Phone: +47 91143878 E-mail: petterl@otellocorp.com   About Otello: Otello holds shares in several different businesses, including (i)AdColony which helps publishers monetize their content through advertising and advertisers reach the audiences that build value for their businesses, capitalizing on

TOMRA: SUCCESSFUL ISSUANCE OF UNSECURED BONDS

Reference is made to the Q3-presentation and announcement dated 21 October 2019 regarding contemplated bond issue. TOMRA Systems ASA has today successfully issued a total amount of NOK 1,000m in senior unsecured bonds. The transaction is split in two tranches, both were significantly oversubscribed: - 3Y FRN: NOK 400m with a coupon of 3m Nibor + 0.50 % p.a. - 5Y FRN: NOK 600m with a coupon of 3m Nibor + 0.75 % p.a. The net proceeds will be used for general corporate purposes, including refinancing of existing debt. The settlement date is 14 November 2019 and the bonds will be

Kindred - winner of Sweden´s Best Looking Office

Kindred Group is the proud winner of ‘Sweden´s Best Looking Office’. The competition puts the spotlight on companies that have successfully combined aesthetic and compelling environments with a smart and flexible working space adapted to fit the organisations specific needs. Kindred Group moved into its award-winning, purpose-built facility in April this year.Kindred Group (former Unibet Group) is the proud winner of Sweden´s Best Looking Office. A competition arranged annually by Fastighetssverige and Lokalnytt.se.  Kindred moved into their new office at Urban Escape in central Stockholm

Dicot signs Agreement for Contract Research with Pelvipharm

November 6, 2019, Uppsala, Sweden – Dicot AB (publ) (“Dicot” or the “Company”) announced today that the company has entered into a research collaboration agreement with Pelvipharm, a world-leading contract research organization (CRO) based in France. This research collaboration is focused on the identification of Libiguin’s® mechanisms of action, which is a key step towards defining the exact domain for clinical use of the drug, and to support its registration as an approved drug. Pelvipharm specializes in the field of male and female sexual dysfunctions, offering both in vivo and in

There are no items matching the current filter
There are no more items matching the current filter
Back to top